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In March 2020, we observed an outbreak of COVID-19 
among a relatively homogenous group of 199 young 
(median age 21 years; 87% men) Swiss recruits. By 
comparing physical endurance before and in median 
45 days after the outbreak, we found a significant 
decrease in predicted maximal aerobic capacity in 
COVID-19 convalescent but not in asymptomatically 
infected and SARS-CoV-2 naive recruits. This finding 
might be indicative of lung injury after apparently mild 
COVID-19 in young adults.
The 2019 coronavirus disease (COVID-19) caused by 
the severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) emerged as a pandemic in late 2019, and 
is ongoing at the time of writing. Long-term sequelae 
of COVID-19 are still unknown. Pulmonary sequelae 
impairing physical fitness have been described pre-
dominantly for hospitalised patients with COVID-19 
[1-3]. Although lung lesions have also been described 
in asymptomatically infected individuals [3-5], it is yet 
unclear if these observations correlate with a measura-
ble functional deficit in physical fitness. We performed 
a well-established and validated physical fitness test 
[6] before and after an outbreak of COVID-19 among 
young adult Swiss recruits. By measuring the change 
in predicted maximal aerobic capacity (VO2 max) of not 
infected, asymptomatically infected and convalescent 
COVID-19 individuals, we found a decrease in VO₂ max 
among COVID-19 convalescent but not among asympto-
matically and not infected recruits.
Description of included recruits and 
physical fitness tests
We previously described a COVID-19 outbreak at a 
Swiss Armed Forces Base affecting a cohort of young, 
predominantly male recruits (173 men, 26 women) with 
a median age of 21 years (range: 18–27). Throughout 
military training, recruits who showed symptoms 
had to immediately report to our clinic where they 
were swabbed (oronasopharyngeal) and tested for 
SARS-CoV-2 by reverse transcriptase quantitative 
PCR (RT-qPCR) for the nsp12 and E-gene. The immune 
response was measured with commercial enzyme-
linked immunosorbent assay kits for IgM, IgG (both 
from EDI diagnostics, San Diego, United States) and 
IgA (Euroimmun, Lübeck, Germany). Additionally, we 
performed cross-sectional sampling on 14 April 2020 
to determine the rate of asymptomatic infections [7].
Here we included 199 recruits of two heavily affected 
companies with available information on SARS-CoV-2 
status. Recruits of a further company that was not 
affected by the outbreak were excluded, since they 
had a significantly different sex ratio (only men) from 
the included companies. Participants were grouped by 
infection status into convalescent recruits with symp-
tomatic confirmed COVID-19 (n = 68), asymptomatic 
cases with evidence of viral infection by either PCR 
or serology (n = 77) and a naive group without clinical 
symptoms or laboratory evidence of SARS-CoV-2 infec-
tion (n = 54).
The median time between COVID-19 diagnosis and the 
fitness test was 45 days (range: 31–58 days), while the 
baseline test had been performed 3 months before the 
COVID-19 outbreak at the Armed Forces Base (Table). 
Paired sport data at baseline and after the COVID-19 
outbreak were available for 139 (70%) of the partici-
pants. The main reason for missing sport data was 
medical dispensation, however, the rate of missing 
data was similar throughout all groups.
Aerobic endurance, trunk muscle, and upper extrem-
ity strength are measured by a progressive endurance so
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run (PER), prone bridge test (PBT) and seated shot put 
test (SSP), respectively. Using the final running veloc-
ity of the PER, predicted maximal aerobic capacity 
(VO₂ max) can be calculated [8,9]. Since the local out-
break occurred in-between the two sets of tests, we 
were able to assess physical fitness before and after 
infection with SARS-CoV-2. Statistical significance test-
ing for differences of scalar variables (e.g. VO2  max) 
between the groups were performed with Student’s 
t-test and differences in the contingency tables were 
tested with Fisher’s exact test. p values smaller than 
0.05 were considered as statistically significant.
Decreased maximal aerobic capacity in 
COVID-19 convalescent recruits
We observed a statistically significant decrease in 
VO₂  max among COVID-19 convalescents compared 
with naive and asymptomatically infected recruits 
(Figure). While the median VO₂ max stayed unchanged 
for most recruits, a significant decrease in VO2  max 
of −0.9 ml/min/kg was observed in COVID-19 conva-
lescents if compared with their individual baseline 
measurements before the local outbreak (Figure). Not 
only the difference but also the absolute VO₂ max was 
lower in convalescent as compared with naive recruits 
(p = 0.02, data not shown), although significance was 
lost if COVID-19 convalescents were compared with the 
combined group of asymptomatic and naive recruits 
(p = 0.06, Table). 
Neither of the strength tests (PBT and SSP) differed 
significantly between the three groups (Table).
During military training, fitness is expected to gener-
ally increase. We observed an increase in VO2  max of 
more than 10% in nearly 14% of the naive recruits and 
nearly 8% in the asymptomatic group, while none of 
the COVID-19 convalescent recruits had an increase 
of more than 10%. On the contrary, 19% of the COVID-
19 convalescents had a decrease of more than 10% 
in VO2  max, while none of the naive recruits showed 
such a decrease. While the overall effect of COVID-19 
on VO2  max might be subtle, a significant subset of 
patients seem to have lost more than 10% of their ini-
tial aerobic capacity.
These findings indicate a specific decrease in aerobic 
capacity affecting COVID-19 convalescent recruits com-
pared with naive as well as asymptomatically infected 
ones. VO2 max before the COVID-19 outbreak was very 
similar between the groups, excluding a selection bias 
for preexisting lower scores.
Table
Characteristics of participating recruits, Switzerland, May 2020
Characteristics All groups SARS-CoV-2 naive Asymptomatically infected
COVID-19 
convalescents p value
Recruits (n, %) 199 100% 54 27% 77 39% 68 34% NA
Recruits with complete 
sport data (n, %) 139 70% 36 67% 55 67% 48 71% NS
a
Age (years)b 20.7 (19.9 to 21.8) 20.8 (20.2 to 22.0) 20.8 (19.9 to 21.9) 20.3 (19.8 to 21.5) NA
Fraction of female recruits 
(n, %) 25 13% 6 11% 10 13% 9 13% NA
BMI (kg/m2)b 22.7 (21.4 to 24.8) 22.2 (20.5 to 23.9) 23.1 (21.9 to 25.6) 23.7 (21.9 to 25.5) NA
VO2 max at baseline (ml/
min/kg)b 43.3 (41.8 to 45.1) 43.5 (42.4 to 45.0) 42.8 (41.7 to 44.8) 43.7 (41.5 to 46.0) NS
c
VO2 max (ml/min/kg)
b 42.6 (40.8 to 44.5) 42.8 (42.2 to 45.0) 42.9 (40.9 to 44.2) 41.8 (39.9 to 44.6) NSc (p = 0.06)
Change in VO2 max (ml/
min/kg)b −0.25 (−2.4 to  1.2)  + 0.1 (−1.2 to 1.7) 0 (−2.0 to 1.3) −0.9 (−3.2 to 0.5) p = 0.005
c
Fraction of recruits with 
more than 10% loss in 
VO2 max (n, %)
10 7.2% 0 0.0% 1 1.9% 9 18.8% p < 0.001a
Fraction of recruits with a 
gain of more than 10% in 
VO2 max (n, %)
9 6.5% 5 13.9% 4 7.6% 0 0% p = 0.02a
Upper extremity strength 
 
SSP (m)b
5.8 (5.0 to 6.3) 5.8 (5.4 to 6.2) 5.8 (4.9 to 6.5) 6.0 (5.0 to 6.5) NSc
Trunk strength 
 
PBT (s)b
120 (82 to 180) 130 (115 to 184) 120 (81 to 168) 120 (81 to 149) NSc
COVID-19: coronavirus disease; NA: not applicable; NS: not significant; PBT: prone bridge test; SSP: seated shot put test; SARS-CoV-2: severe 
acute respiratory syndrome coronavirus 2; VO₂ max: maximal aerobic capacity.
a Fisher’s exact test.
b The median and 25%–75% percentiles in brackets.
c Student’s t-test comparing COVID-19 patients to the other two groups.
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Ethical statement
All procedures involving human participants were con-
ducted in accordance with the ethical standards of the 
Declaration of Helsinki, as revised in 2013. The study 
protocol was approved by the ethical committee of the 
Canton of Ticino, Switzerland (BASEC-ID 2020–00623 
CE 3609). Written informed consent of all participants 
was obtained after oral explanations provided in their 
native language (German, French or Italian).
Discussion and conclusions
To our knowledge, changes in endurance or strength 
following SARS-CoV-2 infection, symptomatic or 
not, have not been described until now. We showed 
reduced aerobic capacity in young adult recruits 1 to 
2 months after symptomatic COVID-19 while physical 
strength was unaffected. Ca 19% of COVID-19 conva-
lescent recruits showed a decrease of VO2 max of more 
than 10% as compared with baseline before infection. 
Although our data do not explain the pathophysiology 
behind these findings, reduced VO2 max is a hallmark of 
interstitial lung disease [10]. SARS-CoV-2 infection has 
been described to induce lung damage, even in asymp-
tomatic cases [4]. This indicates the importance of fur-
ther long-term follow-up studies to assess the extent 
and duration of the sequelae, as well as of infection 
prevention to avoid these long-term consequences.
Physical deconditioning or demotivation may explain 
impaired fitness or compliance, respectively. The 
COVID-19 outbreak had a mental and physical impact on 
military personnel: stringent physical distancing meas-
ures, quarantine and isolation restricted possibilities 
for physical activity, and lowered morale. However, we 
would expect deconditioning and lowered test adher-
ence due to demotivation to affect the results for both 
aerobic capacity and physical strength similarly [11], 
which was not the case with our observations.
Other than the described endurance run, we could 
neither conduct more specific tests (such as spirom-
etry) nor perform serial imaging to identify our results’ 
pathophysiology. The cohort has meanwhile been dis-
solved due to the end of military training, thus such 
studies are difficult to perform in our study group. 
Since we studied a relatively homogeneous cohort of 
young, otherwise healthy, and predominantly male 
adults, our findings might not be applicable to other 
population groups.
Our observations were made within 1 to 2 months 
after the diagnosis of COVID-19 and follow-up studies 
should be conducted to determine whether the reduc-
tion in VO2 max is reversible. With ca 44,900 confirmed 
COVID-19 cases in Switzerland [12] as well as over 2.4 
million in the European Union and Economic Area and 
the United Kingdom, respectively [13] and still increas-
ing case numbers, evaluating possible long-term con-
sequences of COVID-19 is becoming more important by 
the day.
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